CI-579,
U 17,660,
U 17660,
U-17,660,
U-17660,
928664-98-6,
4-Isoxazoleboronic acid pinacol ester,
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole,
4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-isoxazole,
MFCD06657891,
Isoxazol-4-ylboronic acid pinacol ester,
AK-36891,
ISOXAZOLE-4-BORONIC ACID PINACOL ESTER,
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-oxazole,
Isoxazole, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-,
LXCICYRNWIGDQA-UHFFFAOYSA-N,
SCHEMBL142345,
EOS147,
AMBA00007,
DTXSID50585938,
KS-000001LQ,
CI-579,
FCH853063,
AKOS006293858,
ZINC169747553,
4-isooxazolylboronic acid pinacol ester,
AB25740,
AM85030,
CS-W001065,
QC-4819,
RP03989,
RTR-029091,
TRA0025990,
BC001107,
DS-13033,
OR350204,
SC-48660,
SY025655,
AX8158785,
ST2405354,
4-Isoxazoleboronic acid pinacol ester, 95%,
4CH-000366,
BB 0261466,
FT-0650294,
Y4727,
MFCD06657891 (97%),
B-4851,
J-513440,
2-(Isoxazole-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborole,
4-(TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2-OXAZOLE,
C9H14BNO3,
ACN-032524,